A new extended-release tablet with hydrocodone was launched in the United States at the end of January.
Hydrocodone combination products such as Vicodin will now be in the same, more-restrictive category as OxyContin and fentanyl under the Controlled Substances Act, the Drug Enforcement Administration announced Thursday.
The federal government is on the verge of tightening access to Vicodin and similar types of painkillers by moving the drugs from Schedule III to Schedule II classification. Long-term care providers have protested this change, saying it will make it more difficult to manage residents' pain.
The U.S. Food and Drug Administration has announced it will seek restricted access to hydrocodone painkillers, prompting a concerned response from long-term care stakeholders.
Bipartisan bills introduced Wednesday in both houses of Congress propose tightening access to hydrocodone painkillers such as Vicodin.
Restricting access to hydrocodone painkillers will require a lengthy process unless Congress takes action, the Food and Drug Administration recently told lawmakers.
An advisory panel has recommended making it more difficult for long-term care residents and others to receive certain painkillers. Providers criticize the proposal, saying it could leave seniors suffering for long periods.
The Food and Drug Administration should "act without delay" in tightening access to hydrocodone painkillers such as Vicodin, Congressional lawmakers urged in a recent letter. The letter was written by Sen. Joe Manchin (D-WV) and signed by a bipartisan group of five other senators and two representatives.
The Food and Drug Administration should "act without delay" in tightening access to hydrocodone painkillers such as Vicodin, Congressional lawmakers urged in a recent letter.
Nursing home residents could be adversely affected if proposed painkiller regulations are put in place, according to experts who spoke at a recent federal hearing.